ZFAS1 and hepatocellular carcinoma: Luo et al. [81] established through multi-phase cohorts that plasma ZFAS1 levels in HCC patients significantly exceed those in healthy controls (P < 0.001) and cirrhotic individuals (P < 0.001), showing positive correlation with AFP levels (P = 0.006).